Medication optimization during clozapine treatment.
Suppes
T
T
Rush
A J
AJ
D015057:1-Naphthylamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D003024:Clozapine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline; D016896:Treatment Outcome; D014635:Valproic Acid / Q000627:therapeutic use
D015057:1-Naphthylamine; D003024:Clozapine; D008094:Lithium; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; D014635:Valproic Acid